41 - Basic Science Abstracts

Moderator(s)

• 

  Declan McCole, PhD (he/him/his)

  Professor of Biomedical Sciences
  University of California, Riverside
• 

  Karen Edelblum, PhD (she/her/hers)

  Associate Professor
  Icahn School of Medicine at Mount Sinai
  New York, New York

Presentations:

• 8:00 AM - 8:10 AM PST

  IL-23-ACTIVATED CELLS PREDICT RESPONSE TO RISANKIZUMAB IN CROHN'S DISEASE
  

  Author: Siyan Cao, MD, PhD (he/him/his) – Washington University School of Medicine

  Author: Kaiming Ma, BS – Washington University School of Medicine

  Author: Parakkal Deepak, MBBS, MS – Washington University School of Medicine
• 8:10 AM - 8:20 AM PST

  IRE1A-XBP1 CONTROLS INNATE LYMPHOID CELLS AND COLITIS-INDUCED FIBROSIS
  

  Author: Siyan Cao, MD, PhD (he/him/his) – Washington University School of Medicine

  Author: Kaiming Ma, BS – Washington University School of Medicine

  Author: Parakkal Deepak, MBBS, MS – Washington University School of Medicine

  Author: Marco Colonna, MD – Washington University School of Medicine
• 8:20 AM - 8:30 AM PST

  CANCELLED - CHARACTERIZATION OF THE JAK INHIBITORS TOFACITINIB AND UPADACITINIB IN HUMAN PRIMARY CELL 3D MODELS OF CROHN'S DISEASE AND ULCERATIVE COLITIS
  

  Author: Rachel Dudum, MS – Organovo Inc.

  Author: Payton Olson, n/a – Organovo Inc.

  Author: Cole Toohey, n/a – Organovo Inc.

  Author: Sherwin Gervacio, n/a – Organovo Inc.

  Author: Caridad Rosette, n/a – Organovo Inc.

  Author: Fabrice Piu, n/a – Organovo Inc.